Answers are grounded in this paper and cite their sources.
NFL chain has significantly increased in MS patients, which substantially strengthens the clinical evidence of the NFL in MS. The NFL may be used as a prognostic biomarker to monitor disease progression, disease activity, and treatment efficacy in the future.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: